The latest research from Fore Pharma, Global Covid-19 Clinical Trial Pipeline Highlights – 2021, provides most up-to-date information on key pipeline products in the global Covid-19 market. It covers emerging therapies for Covid-19 in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this research helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Research Scope:
-
-
- Products by Clinical Trial Stages: Covid-19 pipeline products by clinical trial stages including both early and late stage development – phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
- Drug Mechanism Classes: Covid-19 pipeline products by their dominant mechanism of action / drug class. This helps executives categorize products based on their drug class.
- Company: Covid-19 pipeline products by developing company.
- Short-term Launch Highlights: Find out which Covid-19 pipeline products will be launched in the US and Ex-US till 2026.
-
Summary of Contents:
– Covid-19 phase 3 clinical trial pipeline products
– Covid-19 phase 2 clinical trial pipeline products
– Covid-19 phase 1 clinical trial pipeline products
– Covid-19 preclinical research pipeline products
– Covid-19 discovery stage pipeline products
– Covid-19 pipeline products short-term launch highlights
- Table of Contents
- List of Tables
- List of Figures
- Format
Table of Contents
1. Covid-19 Pipeline by Stages
2. Covid-19 Phase 3 Clinical Trial Insights
3. Covid-19 Phase 2 Clinical Trial Insights
4. Covid-19 Phase 1 Clinical Trial Insights
5. Covid-19 Preclinical Research Insights
6. Covid-19 Discovery Stage Insights
7. Appendix
8. Research Methodology
